news
AstraZeneca issues update on accelerated oncology pipeline in advance of 2013 ASCO Annual Meeting
First patient enrolled in Phase III clinical trial...
16 May 2013 | By AstraZeneca
First patient enrolled in Phase III clinical trial...
List view / Grid view
Bahija Jallal
article
Biologics: Teamwork pays off in race to expand market for monoclonal antibodies
The first biologic drug – infliximab (Remicade) – was launched…
22 October 2012 | By Bahija Jallal, Executive Vice President, Research & Development, MedImmune
The first biologic drug – infliximab (Remicade) – was launched in 1998 with initial sales of USD 500 million per annum. By 2010, Reuters’ top 10 drugs by sales included five biologics (Remicade, Enbrel, Humira, Avastin and Humira) generating around USD 34 billion in revenue, including USD 7.4 billion from…
article
Translational science: The future of medicine
When the term ‘translational medicine’ first came to prominence at…
16 February 2011 | By Bahija Jallal, Executive Vice President, Research & Development, MedImmune
When the term ‘translational medicine’ first came to prominence at the turn of the century, there were suspicions that this concept was simply a rebranding of conventional medical research, describing the process in which scientific discovery at the laboratory bench eventually translates to an effective therapy at the patient’s bedside.…
